Correlation of Stomatitis and Cutaneous Toxicity With Clinical Outcome in Patients With Metastatic Renal-Cell Carcinoma Treated With Everolimus

These data suggest that SCTE may be a predictive marker of favorable outcome in mRCC patients treated with everolimus.